Gavisconell Liquid Mint, Suspension zum Einnehmen in Flaschen
7680669970024
CH-66997
Suspension zum Einnehmen in Flaschen
Associated product:
GAVISCONELL Liquid Mint susp en bouteille 300 ml
1 / 3
google
Article details
- Package size
- 300
- Selling units
- 300
- Measure
- ml
- Galenic form
- Suspension zum Einnehmen in Flaschen
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
267.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
160.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
6.0 MG | Substance | HBESI |
|
(N/A)
|
40.0 MG | Substance | HBESI |
|
(N/A)
|
142.6 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 10.75
Specialties list
Yes
Generic
No
SL addition date:
01/10/2020
Authorization holder
Reckitt Benckiser (Switzerland) AG
8304 Wallisellen
Authorization information
- Swissmedic authorization number
- 66997
- Drug name
- Gavisconell Liquid Mint, Suspension zum Einnehmen in Flaschen
- Galenic form
- SUOR
- ATC Code
- A02AX
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 01/11/2018
- Authorization expiration date
- 31/12/9999
- IT Number
- 04.01.0.
- Domain
- Human medicine
Package details
- Description (FR)
- GAVISCONELL Liquid Mint susp en bouteille 300 ml
- Description (DE)
- GAVISCONELL Liquid Mint Susp in Flasche 300 ml
- Market launch
- 01/11/2018
- Narcotic (BTM)
- No
Other package sizes (1)
None
150 ML
GTIN: None